Dow Up 0.09% Nasdaq Down 0.02%

Transcept Pharmaceuticals, Inc. (TSPT)

-NasdaqGM
2.22 Up 0.05(2.30%) 4:00PM EDT
Prev Close:2.17
Open:2.19
Bid:0.17 x 100
Ask:2.88 x 200
1y Target Est:4.20
Beta:-0.27
Earnings Date:Nov 5 - Nov 10 (Est.)
Day's Range:2.15 - 2.25
52wk Range:1.85 - 3.90
Volume:75,018
Avg Vol (3m):214,374
Market Cap:42.54M
P/E (ttm):N/A
EPS (ttm):-1.05
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for TSPT

Comparison

Symbol% ChgMkt Cap
TSPTUp 2.30%42.54M
APRIDown 3.59%71.63M
PTIEDown 2.09%193.09M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):31.07
Ex-Dividend Date:04-Jun-14

Analysts

Annual EPS Est (Dec-14) :N/A
Quarterly EPS Est (Sep-14) :N/A
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Transcept Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of proprietary products that address therapeutic needs in the field of neuroscience. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback